Scapis logo


The aim of the Swedish CArdioPulmonary bioImage Study (SCAPIS) is to predict and prevent cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD). The goal is to further develop individualised treatment and improve health care by building a nationwide, open-access, population-based cohort.

SCAPIS will recruit and investigate 30,000 men and women aged 50 to 64 years with detailed imaging and functional analyses of the cardiovascular and pulmonary systems. The data is collected at six sites in Sweden (Uppsala, Umeå, Linköping, Malmö/Lund, Gothenburg and Stockholm). The study started in 2013 and have currently investigated over 20,000 men and women and is estimated to be completed by the end of 2018, at which point 30,000 subjects will have been included. The novelty and significant contribution of SCAPIS is that it combines size with extensive phenotyping.

SCAPIS is a unique study made possible through a collaborative effort between six Swedish universities (Uppsala University, Umeå University, Linköping University, Lund University, University of Gothenburg and Karolinska Institute) and university hospitals (Uppsala University Hospital, University Hospital of Umeå, Linköping University Hospital, Skåne University Hospital, Sahlgrenska University Hospital and Karolinska University Hospital).

Main funder of SCAPIS is the Swedish Heart-Lung Foundation and with considerable support from Knut and Alice Wallenbergs Foundation, Vinnova, The Swedish Research Council and the participating Universities and University Hospitals.



Investigated participants
(as of October 4, 2018):

30 000



30 000